Multiplikator forward rega marang pendapatan mediwound.com (MDWD)
The forward P/S dynamics reflect the market valuation of MediWound Ltd. (MDWD), where the 14.10 metric indicates the asset's status. MediWound Ltd. develops enzyme-based tissue regeneration products, leveraging US government contracts. Regular cash inflows are driven by NexoBrid sales in hospitals. Strong confidence among burn surgeons solidifies the brand's role as an innovator in the treatment of severe wounds.
mediwound.com - rincian analitis lan metrik utama (MDWD)
- rega saiki lan proyeksi nilai saham:
- rincian kapitalisasi pasar:
- rincian valuasi buku bisnis:
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas MediWound Ltd.|MDWD - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal MediWound|MDWD - Utang agregat perusahaan|Utang marang nilai buku MediWound Ltd|MDWD - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MediWound Ltd.|Indikator likuiditas cepet mediwound.com
- data bathi bisnis lan rasio investasi:
MDWD - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep MediWound Ltd.|MDWD - Pangali rega marang bathi|Prakiraan rega marang bathi MediWound|MDWD - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MediWound Ltd|MDWD - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) MediWound Ltd.|MDWD - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan mediwound.com|MDWD - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep MediWound Ltd.
- rincian pendapatan lan dodolan:
Pambiji fundamental perusahaan:MediWound, Ltd. (MDWD)
For the biopharmaceutical business of MediWound Ltd. (MDWD), this indicator serves as a gauge of market expectations regarding the monetization of future sales amid regulatory risks and raw material logistics vulnerabilities. By analyzing the company's modeled P/S, an investor determines the value of one dollar of expected revenue, where an upward trend confirms market confidence in the successful expansion of technologies, while a decline signals a revaluation of asset costs.
Pesaing wigati
Multiplikator Forward P/S HCA (HCA Healthcare)|Rasio kapitalisasi marang dodolan sing dikarepake Tenet Healthcare Corp (THC)|FMS: Multiplikator forward rega marang pendapatan|Solventum Health (SOLV) - Multiplikator forward rega marang pendapatan|Encompass Health (EHC) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Universal Health Services, Inc. (UHS)|Multiplikator forward rega marang pendapatan DVA|Multiplikator Forward P/S RadNet Inc|Rasio rega marang prakiraan pendapatan Option Care Health Inc (OPCH)|Surgery Partners Group - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S PINC (Premier, Inc.)|EYE: Kapitalisasi marang prakiraan pendapatan|PGNY: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ARDT (Ardent Health)|Select Medical Corp (SEM) - Rasio rega marang prakiraan pendapatan|ASTH (Astrana Corp) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan MD|USPH (US Physical Therapy Inc) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S PNTG|Organogenesis Holdings Inc. - Kapitalisasi marang prakiraan pendapatan|Nutex Health Corp - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Auna Corp (AUNA)|SBC - Rasio rega marang prakiraan pendapatan|evolus.com (EOLS) - Multiplikator forward rega marang pendapatan|CYH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan SKIN|Multiplikator forward rega marang pendapatan BTMD|Multiplikator forward rega marang pendapatan The Joint (JYNT)|Multiplikator Forward P/S DCGO|p3hp.org - Kapitalisasi marang prakiraan pendapatan|Gain Therapeutics - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake EUDA (EUDA Health Holdings)|BMGL - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CLGN (CollPlant Biotechnologies)|CUPR: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Multiplikator Forward P/S|Multiplikator Forward P/S MEDIROM Healthcare Group Inc.|Multiplikator forward rega marang pendapatan ALBT (Avalon GloboCare)|Rasio rega marang pendapatan sing dikarepake DHAI|Rasio rega marang prakiraan pendapatan Longevity Health Holdings XAGE|NIVF - Multiplikator forward rega marang pendapatan|ATI Physical Therapy Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CareMax Inc.|Kindly MD Corp (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Multiplikator forward rega marang pendapatan NVOS|SSY (SunLink Health Systems, Inc) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan IMAC Holdings (BACK)
